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Background: We characterized 100 USA100 epidemic MRSA from individuals in the community with no known
healthcare-associated risk factors.
Findings: Molecular epidemiology demonstrated 21 pulsed-field types and six spa types. SCCmec typing
demonstrated that all of the strains possess the type II cassette. The staphylococcal enterotoxin D virulence gene
was also present.
Conclusion: Characterization of USA100 MRSA in the community illustrated the importance of nasal carriage, and
the genetic diversity of the USA100 clone.
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Staphylococcus aureus has produced multiple highly suc-
cessful antibiotic-resistant epidemic clones. Among the
methicillin-resistant S. aureus (MRSA), are the extensi-
vely researched USA300 and the less well characterized
USA100 MRSA. Historically, USA300 was described as a
community-associated MRSA (CA-MRSA) causing di-
sease in healthy individuals (Chambers 2005; McDougal
et al. 2003). Recently the USA300 CA-MRSA designa-
tion has been challenged as this pathogen is repeat-
edly identified as the cause of hospital-acquired MRSA
(HA-MRSA) infection. Regardless of the environment
from which the strains are isolated, the complement of
virulence factors demonstrated in USA300 strains is iden-
tical. In contrast, USA100 is considered an HA-MRSA
and a cause of invasive infection primarily among persons
with healthcare-associated risk factors (Klevens et al.
2007; Limbago et al. 2009). Although detected in nasal
swabs from non-institutionalized individuals (Tenover
et al. 2008), USA100 MRSA have not been well descri-
bed in the community environment, the goal of the pre-
sent study. Herein we characterize 100 USA100 MRSACorrespondence: jroberts@health.usf.edu
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with no known healthcare contact by pulsed-field type
(PFT), spa type (ST), SCCmec type, and PCR identification
of virulence factors. Our results are compared to those
reported for USA100 healthcare-associated isolates.
A total of 100 CA-MRSA from a previously described
report were used in this study (Roberts et al. 2006). The
control, USA100 (NRS382), was obtained from the Net-
work on Antimicrobial Resistance in S. aureus (NARSA).
PFGE was performed as previously described (Roberts
et al. 2006). Genomic DNA from 100 isolates was extrac-
ted using the MagNA PureW and the MagNA Pure LC
DNA Isolation Kit III (Roche Diagnostics, Indianapolis,
IN) according to manufacturer’s instructions. Typing
using the polymorphic region of the spa gene and
SCCmec characterization were performed as previously
described (Oliveira & de Lencastre 2002; Shopsin et al.
1999). PCR detection of lukPV (Lina et al. 1999), seb, tst,
sed (Monday & Bohach 1999) and psmα (Wang et al.
2007) genes was performed as previously reported.
Following our report of USA300 among community-
associated S. aureus (Roberts et al. 2006) our laboratory
continued to characterize MRSA from individuals with
no known healthcare-associated risks using PFGE. Al-
though the majority of isolates added to our collection are
USA300 MRSA, we have also identified a large numberen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Variation in pulsed-field Patterns of USA100 MRSA. N1 Number of isolates included in the PFT (pulsed-field type) including control
strains. Figure 1 Pulsed-field gel electrophoresis classified the majority of the USA100 strains to PFTs 1 (24 isolates including the control strain
USA100/NRS382) and PFT 6 (20 isolates). Representative strains for each of the six spa types are shown included three isolates which possessed
known repeats but not known repeat patterns and therefore could not be typed (unknown unkA-C). The two typing techniques were not always
in agreement as demonstrated by isolates CBD0707 and CBD1031 which possess the same pulsed-field type (Chambers 2005) but different spa
types (151 and unkC).
Table 1 Summary of results for 100 USA100 Epidemic
MRSA
Molecular typing Virulence factor PCR
USA100 SCCmec II spa type1 sed psmα
Nose 47 47 2,151 45 (96%) 47 (100%)
Wound 27 27 2,586,C 26 (96%) 27 (100%)
Blood 13 13 2,A 12 (82%) 13 (100%)
Urine 4 4 2 3 (75%) 4 (100%)
Other 4 4 2,151,B 3 (75%) 4 (100%)
Lung 3 3 2 3 (100%) 3 (100%)
Unknown 2 2 2 2 (100%) 2 (100%)
Total 100 (100%) 100 (100%) NA 94 (94%) 100 (100%)
1spa types identified for each disease etiology are listed. A-C are unknown spa
types.
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studies which have characterized USA100 strains pri-
marily from healthcare environments by PFGE have de-
monstrated great diversity in the USA100 pulsed-field
types (PFTs) (McDougal et al. 2003; Limbago et al. 2009;
Tenover et al. 2008). Similarly, our study of community-
associated USA100 MRSA using PFGE illustrated sub-
stantial diversity among the strain patterns as represented
by 21 PFTs for the 100 isolates (Simpson’s discriminatory
index = 0.920). Reportedly, USA100 MRSA preferentially
classify in three PFGE patterns (40.7% of strains) among
mostly hospital-associated isolates (Limbago et al. 2009).
In the present study, the majority of community USA100
strains possess two PFTs (44% of strains) (Figure 1).
Nasal colonization studies have identified USA100
MRSA as the most common MRSA colonizing non-ins-
titutionalized individuals in the United States (Tenover
et al. 2008). Characterization of these isolates is im-
portant in part because of the established link between
S. aureus nasal carriage and staphylococcal disease.
Tenover et al. specifically queried nasal strains and
found 44.8% of isolates possess USA100 PFTs (Tenover
et al. 2008). In the present study we worked in the op-
posite direction querying first for USA100 PFTs then
identifying etiology. Given the results of the aforemen-
tioned study, it is consistent that we found 47 isolates
(47%) of our strains identified as USA100 were from na-
sal swabs (Table 1). Other common sources of USA100
MRSA were wound (27%) and blood samples (13%)consistent with the prevalence of USA100 MRSA in inva-
sive infections (Klevens et al. 2007; Limbago et al. 2009).
Previous studies have demonstrated USA100 MRSA
are relatively uniform in SCCmec type and spa ge-
nes, typically containing SCCmec II and spa type 2
(TJMBMDMGMK) (McDougal et al. 2003; Limbago
et al. 2009; Tenover et al. 2008). In rare cases, USA100
isolates have been identified which contain SCCmec IV
(Tenover et al. 2008). We performed SCCmec typing and
determined that all of our community USA100 harbor
SCCmec type II (Table 1). We then performed spa typing
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spa types (Table 1). To our knowledge, McDougal et al.
(McDougal et al. 2003) is the only published study with
spa typing results for a large number of USA100 isolates
and the HA-MRSA reported therein were uniformly spa
type 2 (McDougal et al. 2003). A total of 90% of our
isolates were also spa type 2 (Table 1) and the additional
spa types (Table 1) we identified is consistent with data
(unpublished) for USA100 strains in the spa database
(SpaServer.ridom.de).
Virulence factor characterization for USA100 MRSA
has largely centered on the presence of staphylococcal
enterotoxin D. The presence of the sed gene in a MRSA
strain is in fact considered highly predictive of USA100
(Limbago et al. 2009; Tenover et al. 2008). The percent-
age of sed positive strains by PCR in our isolates was
higher than previously reported (94%) (Limbago et al.
2009; Tenover et al. 2008) (Table 1). Additional viru-
lence genes were selected based on their ability to cause
diseases in the community including toxic shock, food
poisoning (seb), necrotizing fasciitis and necrotizing
pneumonia (psmα and lukPV). All of our isolates were
positive for the psmα gene (Table 1), however previous
studies have demonstrated that USA100 strains lack
PSM protein production despite the presence of the
gene (Wang et al. 2007). Finally, although toxic shock
toxin, Panton-Valentine leukocidin, and staphylococcal
enterotoxin B have rarely been reported in USA100
MRSA (Limbago et al. 2009), we failed to detect any of
these virulence factors among our community USA100
MRSA (data not shown).
In conclusion, our study has demonstrated that USA100
MRSA are present in the community among individuals
with no known healthcare contact. Comparison to existing
studies has illustrated that the pathogen is essentially
identical with respect to diversity of pulsed-field types,
anatomical location, SCCmec type and virulence factor
complement irrespective of the environment from which
it was isolated. Perhaps the most significant finding of our
study is that when USA100 is found in the community it
is most often in the nose. It is tempting therefore to
hypothesize that the success of this epidemic clone is par-
tially related to its ability to silently colonize a host. Con-
sidering USA100 is the leading cause of invasive MRSA
infection, that almost all vancomycin-resistant and inter-
mediate S. aureus strains are USA100, and that antibiotic
resistance in USA100 isolates is increasing, the import-
ance of continued surveillance for this pathogen cannot
be understated.
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